interstitial lung disease
Showing NaN - NaN of 10
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil
Recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 16, 2022
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease Trial in Worldwide (PRA023 IV, Companion diagnostic ( CDx),
Recruiting
- Diffuse Cutaneous Systemic Sclerosis
- Interstitial Lung Disease
- PRA023 IV
- +2 more
-
Los Angeles, California
- +13 more
Jul 12, 2022
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Pulmonary Arterial Hypertension, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Treprostinil)
Completed
- Pulmonary Arterial Hypertension
- +2 more
-
Los Angeles, CaliforniaDavid Geffen School of Medicine, UCLA
Sep 7, 2020
Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma Trial in Worldwide (Pomalidomide (CC-4047), Placebo)
Terminated
- Scleroderma, Systemic
- +4 more
- Pomalidomide (CC-4047)
- Placebo
-
Los Angeles, California
- +55 more
Oct 16, 2019
Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Los Angeles (sildenafil)
Withdrawn
- Pulmonary Arterial Hypertension
- +3 more
-
Los Angeles, CaliforniaDavid Geffen School of Medicine UCLA
Apr 27, 2018
Scleroderma, Interstitial Lung Disease Trial in United States (Mycophenolate mofetil, Cyclophosphamide, Placebo)
Completed
- Scleroderma
- Interstitial Lung Disease
- Mycophenolate mofetil
- +2 more
-
Los Angeles, California
- +13 more
Feb 6, 2017
